Biotron 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases  1 Product   3 Trials   22 News 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIT 225 / Biotron
ACTRN12621001354875p: An open-label study of the safety and efficacy of 12 weeks treatment with BIT225 and Combination Antiretroviral Therapy (cART) in patients with Human Immunodeficiency Virus-1 (HIV-1) with only partial immune reconstitution.

Not yet recruiting
2
20
 
Biotron Limited, Biotron Limited
Human Immunodeficiency Virus-1 infection
 
 
ACTRN12621000937819p: A study of the safety and efficacy of 6 months treatment with BIT225 and Combination Antiretroviral Therapy (cART) in patients with Human Immunodeficiency Virus-1 (HIV-1) compared to cART alone, including measurement of BIT225 in the blood, antiviral activity and immune markers.

Not yet recruiting
2
27
 
Biotron Limited, Biotron Limited
Human Immunodeficiency Virus-1 infection
 
 
ACTRN12623000035628: A study of the safety and efficacy of 7 days treatment with BIT225 in patients with COVID-19, compared to placebo, including measurement of antiviral activity, clinical recovery and immune biomarkers.

Not yet recruiting
2
60
 
Biotron Limited, Biotron Limited
COVID-19
 
 
ACTRN12621000937819: A study of the safety and efficacy of 6 months treatment with BIT225 and Combination Antiretroviral Therapy (cART) in patients with Human Immunodeficiency Virus-1 (HIV-1) compared to cART alone, including measurement of BIT225 in the blood, antiviral activity and immune markers.

Completed
2
27
 
Biotron Limited, Biotron Limited
Human Immunodeficiency Virus-1 infection
 
 
ACTRN12621001354875: An open-label study of the safety and efficacy of 12 weeks treatment with BIT225 and Combination Antiretroviral Therapy (cART) in patients with Human Immunodeficiency Virus-1 (HIV-1) with only partial immune reconstitution.

Completed
2
20
 
Biotron Limited, Biotron Limited
Human Immunodeficiency Virus-1 infection
 
 
Anti-viroporin therapeutics / Biotron
No trials found
Undisclosed HBV therapeutic / Biotron
No trials found

Download Options